当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors.
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2007 Jan 25 , DOI: 10.1021/jm060653b
Thomas A. Chappie 1 , John M. Humphrey 1 , Martin P. Allen 1 , Kimberly G. Estep 1 , Carol B. Fox 1 , Lorraine A. Lebel 1 , Spiros Liras 1 , Eric S. Marr 1 , Frank S. Menniti 1 , Jayvardhan Pandit 1 , Christopher J. Schmidt 1 , Meihua Tu 1 , Robert D. Williams 1 , Feng V. Yang 1
Affiliation  

A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal point for additional modeling, X-ray, and synthetic efforts toward increasing PDE10A inhibitory potency and selectivity versus PDE3A/B. These efforts culminated in the discovery of 29, a potent and selective brain penetrable inhibitor of PDE10A.

中文翻译:

发现了一系列6,7-二甲氧基-4-吡咯烷基喹唑啉PDE10A抑制剂。

通过SBDD生成了基于罂粟碱的PDE10A抑制药效团模型,并用于设计4-氨基-6,7-二甲氧基喹唑啉的文库。从该文库中出现了芳基醚吡咯烷基6,7-二甲氧基喹唑啉系列,该系列成为了其他建模,X射线和合成努力的重点,以提高PDE10A的抑制力和选择性(相对于PDE3A / B)。这些努力最终导致了29种PDE10A的有效和选择性脑可渗透抑制剂的发现。
更新日期:2017-01-31
down
wechat
bug